BDTX - Intrinsic Value and Financial Analysis - Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. BDTX

Healthcare - Biotechnology - NASDAQ - US

Watchlist

$ 2.62

-8.07 %

$ 148 M

Market Cap

-2.15

P/E

Price Target Average

441.98%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

18.92%

Net Income Estimate

12.04%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Black Diamond Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for BDTX of $14.2 , with forecasts ranging from a low of $11 to a high of $20 .

BDTX Lowest Price Target Wall Street Target

11 USD 319.85%

BDTX Average Price Target Wall Street Target

14.2 USD 441.98%

BDTX Highest Price Target Wall Street Target

20 USD 663.36%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Premium Plan